INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the role, safety, and effectiveness of intravitreal conbercept (KH902) injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Retina (Philadelphia, Pa.)

Title: Retina (Philadelphia, Pa.)

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1539-2864

ISSN (Print): 0275-004X

Publication date (Electronic): May 2016

Volume: 36

Issue: 5

Affiliations

[1 ] *Tianjin Medical University Eye Center, Tianjin Medical University Eye Institute, Tianjin, China; and †Tianjin Children Hospital, Tianjin, China.

Article

DOI: 10.1097/IAE.0000000000000900

PubMed ID: 26630313

SO-VID: 80efc519-e0dc-43ad-bb53-cc77096d4dd6

History

Data availability:

Comments

Comment on this article

scite_

Cited by 33

See all cited by